Glimepiride CAS 93479-97-1 Assay 98.0%~102.0% API Factory Maemaʻe Kiʻekiʻe

Glimepiride CAS 93479-97-1 Assay 98.0%~102.0% API Factory Maʻemaʻe Kiʻekiʻe

ʻO ka wehewehe pōkole:

Inoa Kemika: Glimepiride

CAS: 93479-97-1

ʻAno: Pahu keʻokeʻo a ʻaneʻane keʻokeʻo

ʻIke: 98.0%~102.0%

ʻO Glimepiride i ka mālama ʻana i ka noninsulin-Dependent Type 2 Diabetes Mellitus

API no ke kūlana kiʻekiʻe, hana kālepa

Inquiry: alvin@ruifuchem.com

E hoʻouna i ka leka uila iā mākou

Huahana Huahana

Nā Huahana Pili

Huahana Huahana

wehewehe:

Hoʻolako me ka maʻemaʻe kiʻekiʻe a me ka maikaʻi paʻa
Inoa Kemika: Glimepiride
CAS: 93479-97-1
ʻO Glimepiride i ka mālama ʻana i ka noninsulin-Dependent Type 2 Diabetes Mellitus
API no ke kūlana kiʻekiʻe, hana kālepa

Na Waiwai Kemika:

Inoa Kimia	ʻO Glimepiride
Nā huaʻōlelo like	Amaryl
Helu CAS	93479-97-1
Helu CAT	RF-API24
Kūlana Kūʻai	Ma ka waihona, hoʻonui ʻia a hiki i nā tona
ʻĀpana Molekala	C24H34N4O5S
Kaumaha Molecular	490.62
Lae hehee	212.2—214.5 ℃
Kūlana Hoʻouna	Ma lalo o ka mahana wela
Brand	Kemika Ruifu

Nā kikoʻī:

'ikamu	Nā kikoʻī
Ka nana aku	Pauda keʻokeʻo a ʻaneʻane keʻokeʻo
ʻIkepili	IR (e like me ka maʻamau)
Na mea pili
Cis-Isomer (A)	≤0.80%
Sulfonamide (B)	≤0.40%
Uretana (C)	≤0.10%
3-Isomer (D)	≤0.20%
ʻO nā mea haumia ʻē aʻe	≤0.10%
Huina paumaele	≤0.50%
Nalo ma ka maloo	≤0.50%
Koena ma ka Ignition	≤0.10%
Nā Metala Kaumaha	≤0.001%
Hoʻāʻo	98.0%~102.0%
Kūlana hoʻāʻo	ʻEulopa Pharmacopeia (EP);ʻAmelika Hui Pū ʻIa Pharmacopoeia (USP)
Hoʻohana	Mea Hana Lapaʻau Hoʻoikaika (API)

Pūʻolo a me ka waiho ʻana:

Pūʻolo: ʻO ka ʻōmole, ʻeke ʻeke alumini, pahu pahu pahu, 25kg / pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.

Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;Palekana mai ka malamalama, ka ma'ū a me ka pest infestation.

Pono:

FAQ:

Noi:

ʻO Shanghai Ruifu Chemical Co., Ltd. ka mea hana nui a me ka mea hoʻolako o Glimepiride (CAS: 93479-97-1) me ke kiʻekiʻe kiʻekiʻe, ka lāʻau lapaʻau ikaika (API).ʻO Glimepiride kahi lāʻau antidiabetic e kōkua i ka mālama ʻana i ke kō koko.ʻO Glimepiride kahi sulfonylurea hana lōʻihi, ke kolu o ka hanauna me ka hana hypoglycemic.

ʻO Glimepiride (inoa kālepa kumu ʻo Amaryl) kahi lāʻau lapaʻau antidiabetic medium-to-long-acting sulfonylurea antidiabetic.E like me nā sulfonylureas āpau, hana ʻo glimepiride ma ke ʻano he huna huna o ka insulin.Hoʻohaʻahaʻa ia i ke kō koko ma ka hoʻoulu ʻana i ka hoʻokuʻu ʻana o ka insulin mai ka hana ʻana o nā pancreatic beta cell a me ka hoʻonui ʻana i ka naʻau o nā ʻiʻo peripheral i ka insulin.Hoʻopaʻa paha ʻo Glimepiride i ka ATP-sensitive potassium channel receptors ma ka ʻili o ka cell pancreatic, e hōʻemi ana i ka conductance potassium a me ka depolarization o ka membrane.Hoʻoulu ʻia ka depolarization membrane i ka komo ʻana o ka calcium ion ma o nā kahawai calcium-sensitive.ʻO kēia hoʻonui ʻana i ka hoʻonui ʻana o ka calcium ion intracellular e hoʻoulu i ka huna ʻana o ka insulin.Hoʻohana nui ʻia ʻo Glimepiride e mālama i nā poʻe maʻi me ka maʻi diabetes type 2 a hiki ke hōʻemi i ka manawa e ulu ai kekahi i nā hoʻopiʻi o ka maʻi diabetes type 2.Ua ʻae ʻia ka lāʻau lapaʻau e ka FDA ma 1995 a ua hana ʻia e Sanofi-Aventis.Hiki ke hoʻohana pū ʻia me ka papahana ʻai kūpono a me ka hoʻoikaika kino a hiki ke hoʻohana wale ʻia a i ʻole me nā lāʻau antidiabetic ʻē aʻe inā pono.Hiki ke hoʻohana ʻia ʻo Glimepiride ma ke ʻano he monotherapy a i hui pū ʻia me ka insulin.